Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302Fanying Meng, Charles P. Hart, Deepthi Bhupathi et al.|Molecular Cancer Therapeutics|2011Cited by 206
In vivo correction of anaemia in β-thalassemic mice by γPNA-mediated gene editing with nanoparticle deliveryRaman Bahal, Peter M. Glazer|Nature Communications|2016Cited by 183
Potentiation of Temozolomide Cytotoxicity by Inhibition of DNA Polymerase β Is Accentuated by BRCA2 MutationGregory C. Stachelek, Peter M. Glazer|Cancer Research|2009Cited by 34
Synthetic lethality of a cell-penetrating anti-RAD51 antibody in PTEN-deficient melanoma and glioma cellsAudrey Turchick, Peter M. Glazer|Oncotarget|2019Cited by 31
Next-generation cell-penetrating antibodies for tumor targeting and RAD51 inhibitionMadison Rackear, Peter M. Glazer|Oncotarget|2024Cited by 7